A Lower-Risk Way To Play This “High-Octane” Healthcare Trend
A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…
A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…
With the global biotechnology market expected, by one estimate, to almost double from its $448 billion level last year to $833 billion by 2027, today’s…
When it comes to biotech stocks, the author of today’s article advises that “While you can get access to many of these firms via exchange-traded…
If exposure to cutting-edge innovations in the healthcare industry is what you’re after, consider the exchange-traded fund highlighted in today’s article, which focuses on potential…
While the authors of today’s article are stock pickers, they argue that there are some situations where exchange-traded funds are the better option – and…
When it comes to the violent swings experienced by the stock market over the last few weeks, the author of today’s article points out that…
For those investing for the long-term, the best thing to do in response to current market turmoil, driven by fears surrounding the novel coronavirus, may…
The trading strategy highlighted in today’s article, which uses the world’s largest exchange-traded fund (the SPDR S&P 500 ETF, or SPY) “has yielded more than…
With increased market turbulence of late, today’s article highlights one way that investors can hedge against wild market swings: exchange traded funds focused on lower…
The first quarter of 2019 saw the best return for the S&P 500 of the last 21 years. It should not be surprising, then, that…